Holen Sie sich die Stockscreener-App
4.49
0.66%
-0.03
Handel nachbörslich:
4.49
Schlusskurs vom Vortag:
$4.52
Offen:
$4.49
24-Stunden-Volumen:
7.72M
Relative Volume:
5.85
Marktkapitalisierung:
$207.03M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-147.71M
KGV:
-1.2522
EPS:
-3.5857
Netto-Cashflow:
$-127.89M
1W Leistung:
-2.60%
1M Leistung:
+5.15%
6M Leistung:
-64.70%
1J Leistung:
-73.38%
1-Tages-Spanne:
$4.40
$4.49
1-Wochen-Bereich:
$4.40
$4.65
52-Wochen-Spanne:
$3.00
$25.45
Cargo Therapeutics Inc Stock (CRGX) Company Profile
Firmenname
Cargo Therapeutics Inc
Sektor
Branche
Telefon
650-499-8950
Adresse
835 INDUSTRIAL ROAD, SUITE 400, SAN CARLOS
Vergleichen Sie CRGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRGX
Cargo Therapeutics Inc
|
4.49 | 214.44M | 0 | -147.71M | -127.89M | -3.5857 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Cargo Therapeutics Inc Stock (CRGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-30 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2025-01-30 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-01-30 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2025-01-30 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-01-30 | Herabstufung | Truist | Buy → Hold |
| 2025-01-30 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-11-26 | Eingeleitet | William Blair | Outperform |
| 2024-07-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-08 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-06-27 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-05 | Eingeleitet | JP Morgan | Overweight |
| 2023-12-05 | Eingeleitet | Jefferies | Buy |
| 2023-12-05 | Eingeleitet | TD Cowen | Outperform |
| 2023-12-05 | Eingeleitet | Truist | Buy |
Alle ansehen
Cargo Therapeutics Inc Aktie (CRGX) Neueste Nachrichten
CARGO Therapeutics Inc. Stock Analysis and ForecastConsistent double returns - jammulinksnews.com
Is CARGO Therapeutics Inc. a good long term investmentMarket-crushing stock picks - jammulinksnews.com
What analysts say about CARGO Therapeutics Inc. stockConsistently superior profits - jammulinksnews.com
What drives CARGO Therapeutics Inc. stock priceSuperior investment outcomes - jammulinksnews.com
How CARGO Therapeutics Inc. stock performs during market volatilityFree Capital Allocation Plans - Newser
What makes CARGO Therapeutics Inc. stock price move sharplyFree Predictions - Newser
Why CARGO Therapeutics Inc. stock attracts strong analyst attentionFree Growth Investment Group - Newser
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CRGX, OLO, KLG, GNTY on Behalf of Shareholders - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CARGO Therapeutics, Inc. (NasdaqCRGX), Olo Inc. (NYSEOLO), WK Kellogg Co (NYSEKLG), Guaranty Bancshares, Inc. (NYSEGNTY) - TradingView
Concentra adds CARGO Therapeutics to its biotech buy haul - The Pharma Letter
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives $15.00 Consensus PT from Brokerages - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says - Defense World
Shareholder Alert: The Ademi Firm investigates whether CARGO Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders - The Malaysian Reserve
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of CARGO Therapeutics, Inc. (NASDAQ: CRGX) - TradingView
Huge biotech investor buys 4 Bay Area companies on brink of collapse - SFGATE
Evaluating the Fairness of the Concentra Biosciences Acquisition of CARGO Therapeutics: Is There Undervalued Upside? - AInvest
CARGO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CARGO Therapeutics, Inc.CRGX - Business Wire
Concentra to acquire CARGO Therapeutics for $4.38 per share By Investing.com - Investing.com Nigeria
CARGO Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $4.379 in Cash per Share Plus a Contingent Value Right - ADVFN
Concentra Picks Up Cargo In Latest Troubled Biotech Buyout - insights.citeline.com
Why CARGO Therapeutics Stock Is Gaining Today - Benzinga
New Analyst Forecast: $CRGX Given $5.0 Price Target - Quiver Quantitative
CRGX: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com
Concentra Biosciences, LLC agreed to acquire CARGO Therapeutics, Inc. in a tender offer transaction. - MarketScreener
Jefferies raises Cargo Therapeutics stock price target to $5 on Concentra acquisition - Investing.com Nigeria
Jefferies raises Cargo Therapeutics stock price target to $5 on Concentra acquisition By Investing.com - Investing.com South Africa
Latham Advises Cargo Therapeutics in Acquisition by Concentra Biosciences - Latham & Watkins LLP
Tang Capital makes bid for 4th Bay Area biotech in 3 months, offering to take out Cargo Therapeutics - The Business Journals
Cargo Therapeutics rises on Concentra Biosciences' buyout deal - TradingView
CARGO Therapeutics Announces Merger with Concentra Biosciences - TipRanks
Concentra Biosciences Acquires Cargo Therapeutics For $4.379 Per Share - Finimize
CARGO Therapeutics to be acquired by Concentra Biosciences in $4.379/share cash deal plus CVR; stock rises 8% - Seeking Alpha
Cargo Therapeutics Agrees to be Acquired by Concentra Biosciences - MarketScreener
Concentra to acquire CARGO Therapeutics for $4.38 per share - Investing.com
Cargo Therapeutics enters into agreement to be acquired by Concentra Biosciences - MarketScreener
CARGO Therapeutics Enters into Agreement to Be Acquired by - GlobeNewswire
Major Biotech Deal: Concentra Acquires CARGO Therapeutics at Premium Price Plus Additional Value Rights - Stock Titan
Finanzdaten der Cargo Therapeutics Inc-Aktie (CRGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):